Zum Hauptinhalt springen

Benzodiazepine

15. Februar 2026 | Benzodiazepine

UK: Zusätzliche Warnhinweise für Benzodiazepine, Gabapentin, Pregabalin und Z-Drugs

UK: Zusätzliche Warnhinweise für Benzodiazepine, Gabapentin, Pregabalin und Z-Drugs Die britische Arzneimittelbehörde MHRA verstärkt Warnungen vor Sucht, Abhängigkeit, Entzugssyndrom und Toleranzentwicklung in Fachinformationen und Packungsbeilagen…

25. Januar 2026 | Benzodiazepine

The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative Review.

The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative Review. Freestone J, Kypri S, Schumann JL, Franklin E, Francis C, Barratt MJ, Peacock A, Sutherland R, Clifford B, MacDo…

24. Dezember 2025 | Benzodiazepine

Some illicit benzos 50 times stronger than others

Some illicit benzos 50 times stronger than others The most potent illicit benzodiazepine tablets are more than 50 times stronger than the weakest, according to a new study by King’s College London. Analysing 100 illicit diazepam pills collected ove…

16. November 2025 | Benzodiazepine

Benzodiazepine Use Among Individuals with Opioid Use Disorder: A Narrative Review.

Benzodiazepine Use Among Individuals with Opioid Use Disorder: A Narrative Review. Liu Y, Hong Q, Xie X, Shen W, Chen W, Liu H, Zhou W. Subst Abuse Rehabil. 2025 Oct 21;16:283-291. doi: 10.2147/SAR.S550775. PMID: 41142836; PMCID: PMC12…

16. November 2025 | Benzodiazepine

Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy.

Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy. Ferrer López I, Olry de Labry-Lima A, Gutiérrez-Valencia A, García Bermúdez E, Atienza Martín F, Morente AG, Murillo Fernández MD, Sán…

16. November 2025 | Benzodiazepine

What does data on adverse reactions reveal about benzodiazepines and suicide-related risk?: A disproportionality analysis using FDA FAERS pharmacovigilance data.

What does data on adverse reactions reveal about benzodiazepines and suicide-related risk?: A disproportionality analysis using FDA FAERS pharmacovigilance data. Guo W, Zhang C, Yang R, Yan L. Medicine (Baltimore). 2025 Oct 3;104(40):e…

14. Oktober 2025 | Benzodiazepine

Harm reduction approaches for the use of benzodiazepines: a scoping review.

Harm reduction approaches for the use of benzodiazepines: a scoping review. Morrison C, Natale I, Branchflower A, Harvey C, Lundin RM. Harm Reduct J. 2025 Oct 6;22(1):162. doi: 10.1186/s12954-025-01310-z. PMID: 41053865; PMCID: PMC1250…

Weitere
akutelle Informationen
zu den Themengebieten